Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 82
- Uncategorized
Odor of Burnt Cannabis ‘Insufficient to Provide Probable Cause for Vehicle Search’, Illinois Supreme Court Rules
An Illinois Supreme Court decision has ruled that the smell of burnt cannabis is ‘insufficient to provide probable cause for a police officer to search a vehicle without a warrant’.
- Uncategorized
Leveling the Playing Field: How the SAFER Banking Act will Impact Payments in the Cannabis Industry
By Nan Siler, Vice President Payment Operations at Finix The US cannabis industry is a fast-growing space that is expected to reach $100 billion in sales by 2030.
- Press releases
Leva Clinic Merges with Zerenia to Expand Patient Care and Promote Medical Cannabis as a Pain Management Solution
Leva Clinic, the UK’s first fully digital clinic for pain management, is excited to announce its merger with Zerenia Clinic, a leading integrated healthcare provider.
- Markets & Stocks
Synbiotic’s CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure
Synbiotic [stock_market_widget type=”chart” template=”line” assets=”SBX.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] New research conducted by analysts at NuWays has given German buy-and-build cannabis brand Synbiotic an updated ‘buy’ recommendation.
- Uncategorized
New York Legal Cannabis Sales Could Pass $1bn This Year, According to Regulator
After the rockiest of starts, the regulated marijuana market is finally coming to life in New York state.
- Data & Analysis
Medical Cannabis Legalisation Could Save US Billions in Health Insurance Reductions
US companies in states that have moved to legalize medical cannabis have lower average health insurance costs, according to a new study by Leafwell.
- Uncategorized
Wo sind die geplanten Cannabis-Modellprojekte in Deutschland?
Deutschlands lang erwartete “Säule 2” läuft Gefahr, von der Regierung angesichts der anhaltenden politischen Blockaden sowohl im Inland als auch in der EU aufgegeben zu werden.
- Adult-Use
Where Are Germany’s Planned Cannabis Model Projects?
Germany’s long-anticipated ‘Pillar 2’ is in danger of being abandoned by the government amid ongoing political roadblocks both domestically and from the EU.
- Press releases
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio, is proud to announce its partnership with Georgelle Pharmaceutical Ltd (“Georgelle”), to bring an innovative range of cannabis-based medicines to patients in Ireland.
- Uncategorized
Biden Concedes Rescheduling Is Not a Done Deal as Investor Sentiment Wanes
US President Joe Biden has conceded that cannabis rescheduling is not yet a done deal, and is now almost certain to take place after his term is up.
- Medical
France’s Medical Cannabis Launch Likely to be Delayed Until 2026
Reported by Newsweed.fr While the French National Agency for the Safety of Medicines (ANSM) assured at the beginning of the year that cannabis-based treatments would be available by 2025, it will be difficult to achieve widespread use of medical cannabis in France before 2026.
- Uncategorized
Nebraska Senator Launches Legal Challenge Against Upcoming Medical Cannabis Vote
A former state senator and ex-member of the Nebraska State Board of Health, John Kuehn, has filed a legal challenge aimed at blocking two medical cannabis ballot petitions from appearing on the upcoming November 5 ballot.
